Aurobindo gets control of 7 Actavis plants in Europe

Indian drugmaker Aurobindo has completed its $41 million acquisition of 7 Actavis ($ACT) generic drug facilities across Western Europe. Aurobindo picked up facilities in France, Italy, Spain, Portugal, Belgium, Germany and the Netherlands. The deal included products, marketing authorizations and dossier license rights. They have also struck a long-term agreement for Aurobindo to provide Actavis with APIs. Release | More